Clinical studies recruiting near Warsaw

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migra
Phase 2 · FutureMeds Warszawa Centrum · AbbVie · NCT06602479 KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used W
Phase 1/Phase 2 · Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P · Merck Sharp & Dohme LLC · NCT04165070 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Luxmed Onkologia sp. z o. o. · Eli Lilly and Company · NCT07218380 Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
NA · FutureMeds Warszawa Centrum · Philip Morris Products S.A. · NCT07108166 Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386 A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Investigational Site Number : 6160004 · Sanofi · NCT06867094 A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 3 · Warszawski Uniwersytet Medyczny · Takeda · NCT06747351 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P · Merck Sharp & Dohme LLC · NCT06136559 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P · Merck Sharp & Dohme LLC · NCT06393374 A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Phase 2 · Synexus Polska Sp. z o.o. · Boehringer Ingelheim · NCT06636656 Clinical Trial on Bowel Preparation Comparing Mannitol 100g to Plenvu Both in a Same Day Regimen (CLEARWAY)
Phase 3 · Klinika Reuma Park Sp. z o.o. S.K. · NTC srl · NCT07465705 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P · Pfizer · NCT06758401 A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Instytut Psychiatrii i Neurologii · Bristol-Myers Squibb · NCT06929273 Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compa
NA · Nbr Polska · Hoffmann-La Roche · NCT06704672 A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Phase 3 · Site PL48002 · Astellas Pharma Global Development, Inc. · NCT05970172 Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Followin
Phase 3 · Central Clinical Hospital of the Ministry of Interior and Ad · Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi · NCT07195149 A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Phase 3 · Instytut Pomnik Centrum Zdrowia Dziecka · Alfasigma S.p.A. · NCT06865417 A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Phase 3 · MTZ Clinical Research Powered by PRATIA - PPDS · H. Lundbeck A/S · NCT05897320 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With
Phase 1/Phase 2 · Instytut Hematologii i Transfuzjologii · Hoffmann-La Roche · NCT05987449 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Samodzielny Publiczny Dzieciecy Szpital Kliniczny Im. Jozefa · Boehringer Ingelheim · NCT07355296 A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase 2 · ETG Warszawa · Takeda · NCT07108283 A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Phase 3 · Klinika Reuma Park · Takeda · NCT06671496 A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Ag
Phase 3 · Instytut Matki i Dziecka · Travere Therapeutics, Inc. · NCT06247085 Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Defici
Phase 4 · Centralny Szpital Kliniczny MSWiA w Warszawie · Wroclaw Medical University · NCT05759078 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Instytut Gruzlicy I Chorob Pluc · Hoffmann-La Roche · NCT06793215 A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au
Phase 3 · Local Institution - 0127 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404 Cord Blood S100B Protein Concentration in Neonates With Fetal Growth Restriction
Phase N/A · Institute of Mother and Child · Institute of Mother and Child, Warsaw, Poland · NCT06893926 A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants Wit
Phase 1/Phase 2 · Local Institution - 0105 · Bristol-Myers Squibb · NCT07291076 Angio-based Final Functional Effect of PCI
Phase N/A · Medical University of Warsaw · Medical University of Warsaw · NCT06255678 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Futuremeds Spolka z ograniczona odpowiedzialnoscia · Amgen · NCT07037433

Look up another city

Look up another condition